DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
8.78
+0.15 (1.74%)
At close: Dec 5, 2025, 4:00 PM EST
9.05
+0.27 (3.08%)
After-hours: Dec 5, 2025, 7:19 PM EST
DiaMedica Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 457 | 232 | 108 | 42 | 99 | 190 | |
| Market Cap Growth | 157.60% | 115.41% | 157.97% | -57.63% | -48.10% | 226.30% | |
| Enterprise Value | 402 | 182 | 52 | 6 | 51 | 160 | |
| Last Close Price | 8.78 | 5.43 | 2.84 | 1.58 | 3.73 | 10.14 | |
| PB Ratio | 8.86 | 5.70 | 2.11 | 1.31 | 2.24 | 7.30 | |
| P/TBV Ratio | 8.86 | 5.70 | 2.11 | 1.31 | 2.24 | 7.30 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.00 | 0.01 | |
| Quick Ratio | 10.55 | 8.23 | 19.12 | 15.49 | 29.69 | 13.73 | |
| Current Ratio | 10.67 | 8.28 | 19.27 | 15.61 | 29.82 | 13.77 | |
| Return on Equity (ROE) | -64.12% | -53.27% | -46.77% | -36.06% | -38.81% | -73.10% | |
| Return on Assets (ROA) | -38.34% | -33.18% | -30.02% | -21.89% | -23.16% | -42.73% | |
| Return on Capital (ROIC) | -41.91% | -36.05% | -31.74% | -22.92% | -24.30% | -46.79% | |
| Return on Capital Employed (ROCE) | -64.90% | -65.10% | -41.40% | -43.40% | -31.00% | -48.70% | |
| Earnings Yield | -6.98% | -10.53% | -17.98% | -32.73% | -13.78% | -6.47% | |
| FCF Yield | -6.07% | -9.52% | -17.40% | -27.74% | -12.45% | -4.86% | |
| Buyback Yield / Dilution | -13.70% | -24.07% | -23.16% | -27.29% | -32.48% | -30.80% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.